{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T18:09:40Z","timestamp":1790359780181,"version":"4.1.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"39","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Australian Companion Animal Health Foundation"},{"name":"Feline Health Research Fund"},{"name":"Boehringer Ingelheim, Australia"},{"name":"Australian Postgraduate Award"},{"name":"Neil and Allie Lesue Scholarship"},{"name":"Herbert Johnson Travel Grant Scholarship"},{"name":"Valentine Charlton Bequest"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.vaccine.2016.06.060","type":"journal-article","created":{"date-parts":[[2016,8,11]],"date-time":"2016-08-11T18:00:37Z","timestamp":1470938437000},"page":"4752-4758","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["The protective rate of the feline immunodeficiency virus vaccine: An Australian field study"],"prefix":"10.1016","volume":"34","author":[{"given":"M.E.","family":"Westman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Malik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.M.","family":"Norris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4790","key":"10.1016\/j.vaccine.2016.06.060_b0005","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1126\/science.3643650","article-title":"Isolation of a T-lymphotropic virus from domestic cats with an immunodeficiency-like syndrome","volume":"235","author":"Pedersen","year":"1987","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.vaccine.2016.06.060_b0010","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1097\/QAD.0b013e328013d88a","article-title":"Feline immunodeficiency virus pathogenesis and development of a dual-subtype feline-immunodeficiency-virus vaccine","volume":"21","author":"Yamamoto","year":"2007","journal-title":"AIDS"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2016.06.060_b0015","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.vetmic.2005.11.056","article-title":"Phylogenetic analysis of Portuguese feline immunodeficiency virus sequences reveals high genetic diversity","volume":"114","author":"Duarte","year":"2006","journal-title":"Vet Microbiol"},{"issue":"6","key":"10.1016\/j.vaccine.2016.06.060_b0020","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.1128\/JVI.02090-06","article-title":"Phylogenetic analysis of feline immunodeficiency virus in feral and companion domestic cats of New Zealand","volume":"81","author":"Hayward","year":"2007","journal-title":"J Virol"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2016.06.060_b0025","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.vetimm.2009.10.011","article-title":"Molecular epidemiology of feline immunodeficiency virus in the domestic cat (Felis catus)","volume":"134","author":"Hayward","year":"2010","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.vaccine.2016.06.060_b0030","unstructured":"http:\/\/www.who.int\/gho\/hiv\/en\/."},{"issue":"4","key":"10.1016\/j.vaccine.2016.06.060_b0035","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.jfms.2007.01.007","article-title":"Prevalence of feline immunodeficiency virus infection in domesticated and feral cats in eastern Australia","volume":"9","author":"Norris","year":"2007","journal-title":"J Feline Med Surg"},{"key":"10.1016\/j.vaccine.2016.06.060_b0040","doi-asserted-by":"publisher","DOI":"10.1177\/2055116916646388","article-title":"Seroprevalence of feline immunodeficiency virus and feline leukaemia virus in Australia: risk factors for infection and geographical influences (2011\u20132013)","volume":"2","author":"Westman","year":"2016","journal-title":"J Feline Med Surgery Open Reports"},{"issue":"5","key":"10.1016\/j.vaccine.2016.06.060_b0045","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1111\/j.1751-0813.1997.tb15701.x","article-title":"Prevalences of feline leukaemia virus and feline immunodeficiency virus infections in cats in Sydney","volume":"75","author":"Malik","year":"1997","journal-title":"Aust Vet J"},{"issue":"1","key":"10.1016\/j.vaccine.2016.06.060_b0050","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.jfms.2004.08.005","article-title":"Dual-subtype FIV vaccine (Fel-O-Vax((R)) FIV) protection against a heterologous subtype B FIV isolate","volume":"7","author":"Pu","year":"2005","journal-title":"J Feline Med Surg"},{"issue":"16","key":"10.1016\/j.vaccine.2016.06.060_b0055","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1136\/vr.158.16.561","article-title":"Limited efficacy of an inactivated feline immunodeficiency virus vaccine","volume":"158","author":"Dunham","year":"2006","journal-title":"Vet Rec"},{"issue":"2","key":"10.1016\/j.vaccine.2016.06.060_b0060","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1079\/AHR200487","article-title":"Efficacy and safety of a feline immunodeficiency virus vaccine","volume":"5","author":"Huang","year":"2004","journal-title":"Animal Health Res Rev"},{"issue":"6","key":"10.1016\/j.vaccine.2016.06.060_b0065","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.jfms.2009.12.016","article-title":"Dual-subtype feline immunodeficiency virus vaccine provides 12 months of protective immunity against heterologous challenge","volume":"12","author":"Huang","year":"2010","journal-title":"J Feline Med Surg"},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2016.06.060_b0070","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.vetmic.2005.02.014","article-title":"Dual-subtype vaccine (Fel-O-Vax FIV) protects cats against contact challenge with heterologous subtype BFIV infected cats","volume":"108","author":"Kusuhara","year":"2005","journal-title":"Vet Microbiol"},{"issue":"1","key":"10.1016\/j.vaccine.2016.06.060_b0075","doi-asserted-by":"publisher","first-page":"14","DOI":"10.2174\/157016210790416361","article-title":"Feline immunodeficiency virus model for designing HIV\/AIDS vaccines","volume":"8","author":"Yamamoto","year":"2010","journal-title":"Curr HIV Res"},{"issue":"6","key":"10.1016\/j.vaccine.2016.06.060_b0080","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1016\/j.vaccine.2013.05.024","article-title":"Feline immunodeficiency virus (FIV) vaccine efficacy and FIV neutralizing antibodies","volume":"32","author":"Coleman","year":"2014","journal-title":"Vaccine"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2016.06.060_b0085","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/j.1751-0813.2006.00071.x","article-title":"Vaccine protection against feline immunodeficiency virus: setting the challenge","volume":"85","author":"Hosie","year":"2007","journal-title":"Aust Vet J"},{"key":"10.1016\/j.vaccine.2016.06.060_b0090","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.cimid.2015.07.004","article-title":"Determining the feline immunodeficiency virus (FIV) status of FIV-vaccinated cats using point-of-care antibody kits","volume":"42","author":"Westman","year":"2015","journal-title":"Comp Immun Microbiol Infect Dis"},{"issue":"14","key":"10.1016\/j.vaccine.2016.06.060_b0095","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1136\/vr.128.14.332","article-title":"Transmission of feline immunodeficiency virus from mother to kitten","volume":"128","author":"Callanan","year":"1991","journal-title":"Vet Rec"},{"issue":"6","key":"10.1016\/j.vaccine.2016.06.060_b0100","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.jfms.2007.04.003","article-title":"Quality of different in-clinic test systems for feline immunodeficiency virus and feline leukaemia virus infection","volume":"9","author":"Hartmann","year":"2007","journal-title":"J Feline Med Surg"},{"key":"10.1016\/j.vaccine.2016.06.060_b0105","unstructured":"Litster A, Leutenegger C, Estrada M, Nichols J, Hosie M, Beczkowski P. Diagnostic accuracy of a commercially available PCR test to detect feline immunodeficiency virus antigen. In: 2nd Biennial symposium of ISCAID, San Francisco CA; 2012."},{"key":"10.1016\/j.vaccine.2016.06.060_b0110","unstructured":"http:\/\/www.idexx.com.au\/pdf\/en_au\/smallanimal\/education\/realpcr-test-for-fiv.pdf."},{"issue":"9468","key":"10.1016\/j.vaccine.2016.06.060_b0115","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1016\/S0140-6736(05)66379-9","article-title":"Epidemiology 2 \u2013 compared to what? Finding controls for case-control studies","volume":"365","author":"Grimes","year":"2005","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.vaccine.2016.06.060_b0120","first-page":"1055","article-title":"Field evaluation of vaccine efficacy","volume":"63","author":"Orenstein","year":"1985","journal-title":"Bull World Health Organ"},{"issue":"11","key":"10.1016\/j.vaccine.2016.06.060_b0125","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1086\/652404","article-title":"Vaccine epidemiology: efficacy, effectiveness, and the translational research roadmap","volume":"201","author":"Weinberg","year":"2010","journal-title":"J Infect Dis"},{"issue":"7","key":"10.1016\/j.vaccine.2016.06.060_b0130","doi-asserted-by":"publisher","first-page":"2743","DOI":"10.1007\/s00436-015-4481-4","article-title":"Ivermectin treatment of free-ranging endangered Australian sea lion (Neophoca cinerea) pups effect on hookworm and lice infection status, haematological parameters, growth, and survival","volume":"114","author":"Marcus","year":"2015","journal-title":"Parasitol Res"},{"issue":"12","key":"10.1016\/j.vaccine.2016.06.060_b0135","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1177\/1098612X13491959","article-title":"A door-to-door prevalence study of feline immunodeficiency virus in an Australian suburb","volume":"15","author":"Chang-Fung-Martel","year":"2013","journal-title":"J Feline Med Surg"},{"issue":"3","key":"10.1016\/j.vaccine.2016.06.060_b0140","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1128\/JCM.27.3.474-479.1989","article-title":"Development and evaluation of immunoassay for detection of antibodies to the feline T-lymphotropic lentivirus (feline immunodeficiency virus)","volume":"27","author":"O\u2019Connor","year":"1989","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2016.06.060_b0145","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1099\/0022-1317-72-3-617","article-title":"Characterization of 2 monoclonal antibodies against feline immunodeficiency virus gag gene products and their application in an assay to evaluate neutralizing antibody activity","volume":"72","author":"Fevereiro","year":"1991","journal-title":"J Gen Virol"},{"issue":"8","key":"10.1016\/j.vaccine.2016.06.060_b0150","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.2460\/ajvr.1988.49.08.1246","article-title":"Pathogenesis of experimentally induced feline immunodeficiency virus infection in cats","volume":"49","author":"Yamamoto","year":"1988","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.vaccine.2016.06.060_b0155","first-page":"144","article-title":"FIV, FeLV, and FIPV: interpretation and misinterpretation of serological test results","volume":"vol. 11(3)","author":"Barr","year":"1996"},{"issue":"3","key":"10.1016\/j.vaccine.2016.06.060_b0160","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.jfms.2008.03.002","article-title":"2008 American Association of Feline Practitioners\u2019 feline retrovirus management guidelines","volume":"10","author":"Levy","year":"2008","journal-title":"J Feline Med Surg"},{"issue":"6","key":"10.1016\/j.vaccine.2016.06.060_b0165","doi-asserted-by":"crossref","first-page":"3639","DOI":"10.1128\/JVI.69.6.3639-3646.1995","article-title":"Nucleotide sequence of feline immunodeficiency virus: classification of Japanese isolates into 2 subtypes which are distinct from non-Japanese subtypes","volume":"69","author":"Kakinuma","year":"1995","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2016.06.060_b0170","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1292\/jvms.61.197","article-title":"Feline immunodeficiency virus subtype C is prevalent in northern part of Taiwan","volume":"61","author":"Uema","year":"1999","journal-title":"J Vet Med Sci"},{"issue":"4","key":"10.1016\/j.vaccine.2016.06.060_b0175","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1111\/j.1751-0813.2006.tb13392.x","article-title":"Molecular subtyping of feline immunodeficiency virus from domestic cats in Australia","volume":"84","author":"Kann","year":"2006","journal-title":"Aust Vet J"},{"issue":"10","key":"10.1016\/j.vaccine.2016.06.060_b0180","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1111\/j.1751-0813.2008.00336.x","article-title":"Molecular subtyping of feline immunodeficiency virus from cats in Melbourne","volume":"86","author":"Iwata","year":"2008","journal-title":"Aust Vet J"},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2016.06.060_b0185","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S0165-2427(02)00227-1","article-title":"FIV vaccine development and its importance to veterinary and human medicine: FIV vaccine 2002 update and review","volume":"90","author":"Uhl","year":"2002","journal-title":"Vet Immunol Immunopathol"},{"issue":"10","key":"10.1016\/j.vaccine.2016.06.060_b0190","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.3390\/v3101870","article-title":"Feline immunodeficiency virus (FIV) neutralization: a review","volume":"3","author":"Hosie","year":"2011","journal-title":"Viruses"},{"issue":"3","key":"10.1016\/j.vaccine.2016.06.060_b0195","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.vaccine.2004.05.032","article-title":"Cellular immune responses to feline immunodeficiency virus (FIV) induced by dual-subtype FIV vaccine","volume":"23","author":"Omori","year":"2004","journal-title":"Vaccine"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2016.06.060_b0200","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.vetimm.2006.03.013","article-title":"Lessons from the cat: development of vaccines against lentiviruses","volume":"112","author":"Dunham","year":"2006","journal-title":"Vet Immunol Immunopathol"},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2016.06.060_b0205","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.vetimm.2014.02.014","article-title":"FIV in cats \u2013 a useful model of HIV in people?","volume":"159","author":"Bienzle","year":"2014","journal-title":"Vet Immunol Immunopathol"},{"issue":"10","key":"10.1016\/j.vaccine.2016.06.060_b0210","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1097\/00002030-200107060-00004","article-title":"Dual-subtype FIV vaccine protects cats against in vivo swarms of both homologous and heterologous subtype FIV isolates","volume":"15","author":"Pu","year":"2001","journal-title":"AIDS"},{"key":"10.1016\/j.vaccine.2016.06.060_b0215","unstructured":"http:\/\/www.wsava.org\/sites\/default\/files\/WSAVA%20Vaccination%20Guidelines%202015%20Full%20Version.pdf."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16305114?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16305114?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T17:21:34Z","timestamp":1749057694000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X16305114"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":43,"journal-issue":{"issue":"39","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S0264410X16305114"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.06.060","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The protective rate of the feline immunodeficiency virus vaccine: An Australian field study","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.06.060","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}